Investigators sought to determine if the gemcitabine intravesical system plus intravenous cetrelimab could improve survival for patients with muscle-invasive bladder cancer who did not receive radical ...

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today presented at the 2026 MDA Clinical and Scientific Conference, long-term data from its MESA ...

Plus, tips and testimonials from real women.

Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...

Context Blood flow-restricted resistance exercise (BFR-RE) is used to elicit hypertrophy and strength adaptations with low external loads, making it attractive for clinical and rehabilitative ...

In complex cross-media environments, existing attachment mechanisms face significant physical constraints," said Junzhi Yu, corresponding author and ...

Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move. Dyne Therapeutics, Inc. ( DYN) TD Cowen 46th Annual Health Care Conference March 4, ...

Introduction Older adult loneliness is associated with depression, disability and higher mortality rates. As a public health concern, it contributes to increased medical and nursing care costs.